A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled scientists for years.
Researchers identify genetic mutation in small group of people who developed the serious disorder after receiving the AstraZeneca or Johnson & Johnson vaccine.
Arcturus Therapeutics now centers on ARCT-032 (cystic fibrosis) and ARCT-810 (OTC deficiency), with Covid assets as secondary ...
Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper.
The agency said it denied Moderna’s application because it refused to follow “very clear” guidance. The drugmakers says the FDA approved the design of its clinical trial.
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.
Blood tests revealed that the beverage elicited an immune response, according to preliminary research. But far more safety ...
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health securityStrategic agreement will enable access to Moderna ...
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results